164 related articles for article (PubMed ID: 16102747)
1. Transient lower esophageal sphincter relaxations in dogs are inhibited by a metabotropic glutamate receptor 5 antagonist.
Jensen J; Lehmann A; Uvebrant A; Carlsson A; Jerndal G; Nilsson K; Frisby C; Blackshaw LA; Mattsson JP
Eur J Pharmacol; 2005 Sep; 519(1-2):154-7. PubMed ID: 16102747
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of transient lower esophageal sphincter relaxation and gastroesophageal reflux by metabotropic glutamate receptor ligands.
Frisby CL; Mattsson JP; Jensen JM; Lehmann A; Dent J; Blackshaw LA
Gastroenterology; 2005 Sep; 129(3):995-1004. PubMed ID: 16143137
[TBL] [Abstract][Full Text] [Related]
3. Effects of repeated administration of baclofen on transient lower esophageal sphincter relaxation in the dog.
Lehmann A; Hansson-Brändén L; Kärrberg L
Eur J Pharmacol; 2000 Sep; 403(1-2):163-7. PubMed ID: 10969158
[TBL] [Abstract][Full Text] [Related]
4. Effects of antagonism of NMDA receptors on transient lower esophageal sphincter relaxations in the dog.
Lehmann A; Brändén L
Eur J Pharmacol; 2001 Nov; 431(2):253-8. PubMed ID: 11728433
[TBL] [Abstract][Full Text] [Related]
5. Peripheral versus central modulation of gastric vagal pathways by metabotropic glutamate receptor 5.
Young RL; Page AJ; O'Donnell TA; Cooper NJ; Blackshaw LA
Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G501-11. PubMed ID: 17053158
[TBL] [Abstract][Full Text] [Related]
6. The effects of a novel metabotropic glutamate receptor 5 antagonist (AZD2066) on transient lower oesophageal sphincter relaxations and reflux episodes in healthy volunteers.
Rohof WO; Lei A; Hirsch DP; Ny L; Astrand M; Hansen MB; Boeckxstaens GE
Aliment Pharmacol Ther; 2012 May; 35(10):1231-42. PubMed ID: 22469098
[TBL] [Abstract][Full Text] [Related]
7. Radiofrequency energy delivery to the gastric cardia inhibits triggering of transient lower esophageal sphincter relaxation and gastroesophageal reflux in dogs.
Kim MS; Holloway RH; Dent J; Utley DS
Gastrointest Endosc; 2003 Jan; 57(1):17-22. PubMed ID: 12518124
[TBL] [Abstract][Full Text] [Related]
8. Anticonvulsant activity of two metabotropic glutamate group I antagonists selective for the mGlu5 receptor: 2-methyl-6-(phenylethynyl)-pyridine (MPEP), and (E)-6-methyl-2-styryl-pyridine (SIB 1893).
Chapman AG; Nanan K; Williams M; Meldrum BS
Neuropharmacology; 2000 Jul; 39(9):1567-74. PubMed ID: 10854901
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis and molecular modeling of the binding pocket of the metabotropic glutamate 5 receptor negative modulator 2-methyl-6-(phenylethynyl)-pyridine.
Malherbe P; Kratochwil N; Zenner MT; Piussi J; Diener C; Kratzeisen C; Fischer C; Porter RH
Mol Pharmacol; 2003 Oct; 64(4):823-32. PubMed ID: 14500738
[TBL] [Abstract][Full Text] [Related]
10. Interactive effects of the mGlu5 receptor antagonist MPEP and the mGlu2/3 receptor antagonist LY341495 on nicotine self-administration and reward deficits associated with nicotine withdrawal in rats.
Liechti ME; Markou A
Eur J Pharmacol; 2007 Jan; 554(2-3):164-74. PubMed ID: 17113075
[TBL] [Abstract][Full Text] [Related]
11. The selective metabotropic glutamate receptor 5 antagonist mavoglurant (AFQ056) reduces the incidence of reflux episodes in dogs and patients with moderate to severe gastroesophageal reflux disease.
Rouzade-Dominguez ML; Pezous N; David OJ; Tutuian R; Bruley des Varannes S; Tack J; Malfertheiner P; Allescher HD; Ufer M; Rühl A
Neurogastroenterol Motil; 2017 Aug; 29(8):. PubMed ID: 28337838
[TBL] [Abstract][Full Text] [Related]
12. Antagonism at metabotropic glutamate 5 receptors inhibits nicotine- and cocaine-taking behaviours and prevents nicotine-triggered relapse to nicotine-seeking.
Tessari M; Pilla M; Andreoli M; Hutcheson DM; Heidbreder CA
Eur J Pharmacol; 2004 Sep; 499(1-2):121-33. PubMed ID: 15363959
[TBL] [Abstract][Full Text] [Related]
13. Novel therapeutics for gastro-esophageal reflux symptoms.
Zerbib F; Simon M
Expert Rev Clin Pharmacol; 2012 Sep; 5(5):533-41. PubMed ID: 23121276
[TBL] [Abstract][Full Text] [Related]
14. Transient lower esophageal sphincter relaxations do not result from passive opening of the cardia by gastric distention.
Massey BT; Simuncak C; LeCapitaine-Dana NJ; Pudur S
Gastroenterology; 2006 Jan; 130(1):89-95. PubMed ID: 16401472
[TBL] [Abstract][Full Text] [Related]
15. Transient lower oesophageal sphincter relaxation reducers--have we hit a brick wall?
Hershcovici T; Fass R
Aliment Pharmacol Ther; 2011 Jun; 33(11):1256-7; author reply 1257-8. PubMed ID: 21535056
[No Abstract] [Full Text] [Related]
16. Effect of delta9-tetrahydrocannabinol, a cannabinoid receptor agonist, on the triggering of transient lower oesophageal sphincter relaxations in dogs and humans.
Beaumont H; Jensen J; Carlsson A; Ruth M; Lehmann A; Boeckxstaens G
Br J Pharmacol; 2009 Jan; 156(1):153-62. PubMed ID: 19068079
[TBL] [Abstract][Full Text] [Related]
17. [3H]Methoxymethyl-3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine binding to metabotropic glutamate receptor subtype 5 in rodent brain: in vitro and in vivo characterization.
Anderson JJ; Rao SP; Rowe B; Giracello DR; Holtz G; Chapman DF; Tehrani L; Bradbury MJ; Cosford ND; Varney MA
J Pharmacol Exp Ther; 2002 Dec; 303(3):1044-51. PubMed ID: 12438526
[TBL] [Abstract][Full Text] [Related]
18. Effect of EP1 Receptor Antagonist on Transient Lower Esophageal Sphincter Relaxations in Humans.
Sawada A; Hashimoto A; Uemura R; Yamagami H; Tanigawa T; Watanabe T; Fujiwara Y
Digestion; 2020; 101(3):270-278. PubMed ID: 30897584
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effect caused by MPEP, an antagonist of metabotropic glutamate receptor mGluR5, on seizures induced by pilocarpine in 21-day-old rats.
Jesse CR; Savegnago L; Rocha JB; Nogueira CW
Brain Res; 2008 Mar; 1198():197-203. PubMed ID: 18242586
[TBL] [Abstract][Full Text] [Related]
20. Effects of (2R)-(3-amino-2-fluoropropyl)sulphinic acid (AFPSiA) on transient lower oesophageal sphincter relaxation in dogs and mechanism of hypothermic effects in mice.
Lehmann A; Holmberg AA; Bhatt U; Bremner-Danielsen M; Brändén L; Elg S; Elebring T; Fitzpatrick K; Geiss WB; Guzzo P; Jensen J; Jerndal G; Mattsson JP; Nilsson K; Olsson BM
Br J Pharmacol; 2005 Sep; 146(1):89-97. PubMed ID: 15980875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
